Three patent-pending products delivering AI-powered psychological support — with a licensed clinician in the loop. Built at Next Step Psychology. Validated at Harvard Medical School. Applying for CES 2027 Eureka Park.
AI wellness companion with a licensed psychologist in the loop. Haiku for everyday support; Sonnet for Tier 3 escalation. Crisis detection, clinician dashboard, and SES email alerts built in.
ConsumerClinicalEnterpriseHolographic presence for therapy sessions and human connection. AI segmentation runs on the caller's device — solving thermal endurance and enabling true see-through holography on Snap Spectacles.
Patent PendingTrademarkedXR / ARThe ambient delivery platform — the OS connecting Ambi Chat and Hello Holo into a continuous care continuum. Powered by ABMM, the patented clinician-as-parameter architecture.
Platform OSABMMEnterpriseAmbi Therapy was conceived not in a startup studio but in a psychology practice. After 18 years of clinical work, Ian and Laiza Rumsey set out to solve the single biggest problem in digital mental health: the absence of genuine human presence.
Registered psychologist with 18+ years of clinical practice and 25,000+ contact hours. AHPRA registered, DVA provider, early career at Microsoft and Oracle. Currently enrolled in Harvard Medical School Executive Education — AI in Health Care. Principal architect of Ambi's ABMM methodology and clinical governance framework.
Leads business strategy, commercial operations, and go-to-market across Ambi Therapy and Next Step Psychology. Brings deep operational expertise to a clinical-first founding team — ensuring that what works in the consulting room can scale to 10,000 users and beyond.
Ambi Therapy conceived across a three-day build session. Ambient psychology as infrastructure committed to paper.
CompleteIP Australia filings 2026901412, 2026902711, 2026904294. PCT strategy assessed. Madrid System trade mark prioritised.
Complete13-slide pitch submitted to Harvard AI in Health Care cohort. Ambi Chat backend live. Pre-seed SAFE open at $500K USD / $7M pre-money cap.
Now10-user Ambi Chat pilot under independent clinical professor oversight. First responders grant application (~$1.3M USD) via MRFF/DVA pathways.
NextApplying for a booth at Eureka Park. Qantas QF55 nonstop Sydney–Las Vegas launching December 2026. CES Innovation Award application across XR, Health & Wellness, and Accessibility categories.
Target$3–5M USD seed at $15–20M pre-money. TGA SaMD Class IIa from Month 14. US health system entry via advisory board. Target: 10,000 active users, $152K USD/month revenue.
HorizonAmbi Therapy is applying for a booth at CES 2027 Eureka Park — the world's premier launchpad for breakthrough technology. The same month, Qantas launches QF55 nonstop Sydney to Las Vegas. We plan to be there.
Ambi Therapy is raising its pre-seed round to fund the CES 2027 launch, clinical pilot, PCT patent filings, and the first year of product infrastructure. Early entry into a clinical-grade, patent-protected platform built by Australia's most credentialed mental health founders.
Principal, SIYOM Consulting LLC. Board Chair, Healthix. MIT SM — Brain & Cognitive Sciences. Deep expertise in US health system strategy, enterprise AI governance, and health information exchange. Joined equity-only, unprompted — a strong signal of conviction in the platform.
Independent Clinical Professor in Psychiatry & Psychology. Anchors HREC/IRB oversight for the clinical pilot, provides academic credibility for grants and publications, and connects the platform to MRFF and DVA grant pathways.
Brings strategic expertise and deep professional networks to the Ambi Therapy advisory board. Mike's counsel shapes brand positioning and stakeholder engagement as the platform scales toward CES 2027 and beyond.
Tailored invitations extended to advisors in digital health regulation, enterprise SaaS, and XR/spatial computing. Full advisory board composition announced ahead of CES 2027.
Whether you're an investor, potential advisor, clinical collaborator, or enterprise partner — we'd love to hear from you. Ambi Therapy is a rare combination of deep clinical credibility and patent-protected technology, at the earliest possible entry point.